Chemokines and chemokine receptors in chronic lymphocytic leukemia (CLL): From understanding the basics towards therapeutic targeting

被引:84
作者
Burger, Jan A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Unit 428, Dept Leukemia, Houston, TX 77230 USA
关键词
CLL; Chemokines; Chemokine receptors; CXCR4; Plerixafor; REGULATORY T-CELLS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MALIGNANT B-CELLS; ALPHA MIP-1-ALPHA; CLINICAL ACTIVITY; HODGKIN-LYMPHOMA; NURSELIKE CELLS; TYROSINE KINASE; GENE-EXPRESSION; BONE-DISEASE;
D O I
10.1016/j.semcancer.2010.09.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines and their receptors organize the recruitment and positioning of cells at each stage of the immune response, a system critically dependent upon coordination to get the right cells to the right place at the right time. Chemokine receptors expressed on CLL B cells are thought to function in a similar fashion, regulating the trafficking of the leukemia cells between blood, lymphoid organs, and the bone marrow, and within sub compartments within these tissues, in concert with adhesion molecules and other guidance cues. CLL cells not only respond to chemokines secreted in the microenvironment, the leukemia cells also secrete chemokines in response to external signals, such as B cell receptor engagement. These CLL cell-derived chemokines facilitate interactions between CLL cells, T cells, and other immune cells that shape the CLL microenvironment. CXCR4, the most prominent chemokine receptor in CLL, is now targeted in a first clinical trial, emphasizing that chemokines and their receptors have become a highly dynamic translational research field. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:424 / 430
页数:7
相关论文
共 100 条
[71]   MOLECULAR-CLONING AND STRUCTURE OF A PRE-B-CELL GROWTH-STIMULATING FACTOR [J].
NAGASAWA, T ;
KIKUTANI, H ;
KISHIMOTO, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2305-2309
[72]   Isoform-selective phosphoinositide 3′-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell-mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approach [J].
Niedermeier, Matthias ;
Hennessy, Bryan T. ;
Knight, Zachary A. ;
Henneberg, Marina ;
Hu, Jianhua ;
Kurtova, Antonina V. ;
Wierda, William G. ;
Keating, Michael J. ;
Shokat, Kevan M. ;
Burger, Jan A. .
BLOOD, 2009, 113 (22) :5549-5557
[73]   Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1α [J].
Nishio, M ;
Endo, T ;
Tsukada, N ;
Ohata, J ;
Kitada, S ;
Reed, JC ;
Zvaifler, NJ ;
Kipps, TJ .
BLOOD, 2005, 106 (03) :1012-1020
[74]   The prognostic role of CXCR3 expression by chronic lymphocytic leukemia B cells [J].
Ocana, Esther ;
Delgado-Perez, Luis ;
Campos-Caro, Antonio ;
Munoz, Juan ;
Paz, Antonio ;
Franco, Rafael ;
Brieva, Jose A. .
HAEMATOLOGICA, 2007, 92 (03) :349-356
[75]   High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease [J].
Palacios, Florencia ;
Moreno, Pilar ;
Morande, Pablo ;
Abreu, Cecilia ;
Correa, Agustin ;
Porro, Valentina ;
Ines Landoni, Ana ;
Gabus, Raul ;
Giordano, Mirta ;
Dighiero, Guillermo ;
Pritsch, Otto ;
Oppezzo, Pablo .
BLOOD, 2010, 115 (22) :4488-4496
[76]   CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment [J].
Patten, Piers E. M. ;
Buggins, Andrea G. S. ;
Richards, Julie ;
Wotherspoon, Andrew ;
Salisbury, Jon ;
Mufti, Ghulam J. ;
Hamblin, Terry J. ;
Devereux, Stephen .
BLOOD, 2008, 111 (10) :5173-5181
[77]   Cutting edge: Differential chemokine production by myeloid and plasmacytoid dendritic cells [J].
Penna, G ;
Vulcano, M ;
Roncari, A ;
Facchetti, F ;
Sozzani, S ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6673-6676
[78]   B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406 [J].
Quiroga, Maite P. ;
Balakrishnan, Kumudha ;
Kurtova, Antonina V. ;
Sivina, Mariela ;
Keating, Michael J. ;
Wierda, William G. ;
Gandhi, Varsha ;
Burger, Jan A. .
BLOOD, 2009, 114 (05) :1029-1037
[79]   Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy [J].
Rawstron, AC ;
Kennedy, B ;
Evans, PAS ;
Davies, FE ;
Richards, SJ ;
Haynes, AP ;
Russell, NH ;
Hale, G ;
Morgan, GJ ;
Jack, AS ;
Hillmen, P .
BLOOD, 2001, 98 (01) :29-35
[80]   Matrix metafloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration [J].
Redondo-Munoz, Javier ;
Terol, Maria Jose ;
Garcia-Marco, Jose A. ;
Garcia-Pardo, Angeles .
BLOOD, 2008, 111 (01) :383-386